| pubmed-article:15878723 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15878723 | lifeskim:mentions | umls-concept:C0162429 | lld:lifeskim |
| pubmed-article:15878723 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:15878723 | lifeskim:mentions | umls-concept:C0018546 | lld:lifeskim |
| pubmed-article:15878723 | lifeskim:mentions | umls-concept:C0025265 | lld:lifeskim |
| pubmed-article:15878723 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:15878723 | lifeskim:mentions | umls-concept:C0011155 | lld:lifeskim |
| pubmed-article:15878723 | lifeskim:mentions | umls-concept:C0015744 | lld:lifeskim |
| pubmed-article:15878723 | lifeskim:mentions | umls-concept:C2911691 | lld:lifeskim |
| pubmed-article:15878723 | lifeskim:mentions | umls-concept:C0449243 | lld:lifeskim |
| pubmed-article:15878723 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:15878723 | lifeskim:mentions | umls-concept:C1272706 | lld:lifeskim |
| pubmed-article:15878723 | lifeskim:mentions | umls-concept:C0205191 | lld:lifeskim |
| pubmed-article:15878723 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:15878723 | pubmed:dateCreated | 2005-5-9 | lld:pubmed |
| pubmed-article:15878723 | pubmed:abstractText | Normal participants (n=5) having no experience with antipsychotic drugs and medicated participants (n=5) with clinical experience with chronic low doses of haloperidol (3-10 mg/day for 2-4 months) in the treatment of neuroses were evaluated for the effects of inter-trial interval (ITI) feedback on a discrete-trials peak-interval timing procedure. Feedback was presented during the ITI in the form of a histogram showing the distribution of the responses participants made on the previous trial plotted on a relative time scale. As feedback concerning the accuracy and precision of a reproduced duration (e.g., 7- and 14-s visual signals) became more remote in time, reproduced intervals gradually lengthened in duration. This rightward horizontal shift in peak time increased as a function of the probability of feedback and was enhanced by chronic treatment with haloperidol in a manner that was proportional to the duration of the signal. Our data suggest a gradual change in the underlying representation of the signal duration as a function of the remoteness of ITI feedback that is dependent upon both changes in working memory and the speed of the internal clock used to time durations in the seconds-to-minutes range. | lld:pubmed |
| pubmed-article:15878723 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15878723 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15878723 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15878723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15878723 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15878723 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15878723 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:15878723 | pubmed:issn | 0278-2626 | lld:pubmed |
| pubmed-article:15878723 | pubmed:author | pubmed-author:LustigCindyC | lld:pubmed |
| pubmed-article:15878723 | pubmed:author | pubmed-author:MeckWarren... | lld:pubmed |
| pubmed-article:15878723 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15878723 | pubmed:volume | 58 | lld:pubmed |
| pubmed-article:15878723 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15878723 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15878723 | pubmed:pagination | 9-16 | lld:pubmed |
| pubmed-article:15878723 | pubmed:meshHeading | pubmed-meshheading:15878723... | lld:pubmed |
| pubmed-article:15878723 | pubmed:meshHeading | pubmed-meshheading:15878723... | lld:pubmed |
| pubmed-article:15878723 | pubmed:meshHeading | pubmed-meshheading:15878723... | lld:pubmed |
| pubmed-article:15878723 | pubmed:meshHeading | pubmed-meshheading:15878723... | lld:pubmed |
| pubmed-article:15878723 | pubmed:meshHeading | pubmed-meshheading:15878723... | lld:pubmed |
| pubmed-article:15878723 | pubmed:meshHeading | pubmed-meshheading:15878723... | lld:pubmed |
| pubmed-article:15878723 | pubmed:meshHeading | pubmed-meshheading:15878723... | lld:pubmed |
| pubmed-article:15878723 | pubmed:meshHeading | pubmed-meshheading:15878723... | lld:pubmed |
| pubmed-article:15878723 | pubmed:meshHeading | pubmed-meshheading:15878723... | lld:pubmed |
| pubmed-article:15878723 | pubmed:meshHeading | pubmed-meshheading:15878723... | lld:pubmed |
| pubmed-article:15878723 | pubmed:meshHeading | pubmed-meshheading:15878723... | lld:pubmed |
| pubmed-article:15878723 | pubmed:meshHeading | pubmed-meshheading:15878723... | lld:pubmed |
| pubmed-article:15878723 | pubmed:meshHeading | pubmed-meshheading:15878723... | lld:pubmed |
| pubmed-article:15878723 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15878723 | pubmed:articleTitle | Chronic treatment with haloperidol induces deficits in working memory and feedback effects of interval timing. | lld:pubmed |
| pubmed-article:15878723 | pubmed:affiliation | Department of Psychology, University of Michigan, United States. | lld:pubmed |
| pubmed-article:15878723 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15878723 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15878723 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15878723 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15878723 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15878723 | lld:pubmed |
